Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The pharmacogenomics of osteosarcoma.

The pharmacogenomics journal - 1 Jan 2017

Serra M, Hattinger C M

Abstract excerpt

Osteosarcoma (OS), the most common malignant tumor of bone, is presently treated with multidrug neoadjuvant chemotherapy protocols, which allow to cure 60-65% of patients but also induce toxicity events that cannot be predicted or efficiently prevented. The identification and validation of pharmacogenomic biomarkers is, therefore, absolutely warranted to provide the bases for planning personalized treatments with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Neoplasms
Share to Osteosarcoma
Share to Patient Selection

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pharmacogenetics

Share to Pharmacogenomic Testing

Share to Pharmacogenomic Variants

Share to Precision Medicine

Share to Predictive Value of Tests

Source

Identifiers

PMID: 27241064
DOI: 10.1038/tpj.2016.45

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The pharmacogenomics of osteosarcoma.PMID 27241064Read ↗

Advances in Target Therapy Research in OsteosarcomaSemantic proximity Read ↗

Development of a Risk Model and Genotyping Patterns Based on Disulfidptosis-Related lncRNAs to Predict Prognosis and Immune Landscape in Osteosarcoma.Semantic proximity Read ↗

The role of pharmacogenetics in the treatment of osteosarcomaSemantic proximity Read ↗

Multi-omics analysis identifies osteosarcoma subtypes with distinct prognosis indicating stratified treatmentSemantic proximity Read ↗

Whole-Exome Analysis and Osteosarcoma: A Game Still Open.Semantic proximity Read ↗

Unfolded Protein Response–Related Signature Associates With the Immune Microenvironment and Prognostic Prediction in OsteosarcomaSemantic proximity Read ↗

Construction of an ER stress-related prognostic signature for predicting prognosis and screening the effective anti-tumor drug in osteosarcomaSemantic proximity Read ↗

Development of a novel immune-related genes prognostic signature for osteosarcomaSemantic proximity Read ↗

Future directions in the treatment of osteosarcoma.Semantic proximity Read ↗

Identification of amino acid metabolism-based molecular subtypes and prognostic signature to predict immune landscape and guide clinical drug treatment in osteosarcomaSemantic proximity Read ↗

Genomic and Transcriptomic Characterization of Pre-operative Chemotherapy Response in Patients with OsteosarcomaSemantic proximity Read ↗

Prediction of endoplasmic reticulum stress-related features and indication of immune microenvironment for the prognosis of osteosarcomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.